chr10-46595746-T-C
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The XM_047425825.1(SYT15):c.*620T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.0000077   (  0   hom.,  cov: 19) 
 Failed GnomAD Quality Control 
Consequence
 SYT15
XM_047425825.1 3_prime_UTR
XM_047425825.1 3_prime_UTR
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -2.23  
Publications
0 publications found 
Genes affected
 SYT15  (HGNC:17167):  (synaptotagmin 15) This gene encodes a member of the Synaptotagmin (Syt) family of membrane trafficking proteins. Members of this family contain a transmembrane region and a C-terminal-type tandem C2 domain. Unlike related family members, the encoded protein may be involved in membrane trafficking in non-neuronal tissues. Two trancript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91). 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SYT15-AS1 | ENST00000506914.1  | n.312+2088A>G | intron_variant | Intron 1 of 1 | 4 | |||||
| SYT15-AS1 | ENST00000659936.1  | n.317+2088A>G | intron_variant | Intron 1 of 1 | ||||||
| SYT15-AS1 | ENST00000802578.1  | n.286+2088A>G | intron_variant | Intron 1 of 1 | 
Frequencies
GnomAD3 genomes   AF:  0.00000770  AC: 1AN: 129882Hom.:  0  Cov.: 19 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
1
AN: 
129882
Hom.: 
Cov.: 
19
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  Data not reliable, filtered out with message: AS_VQSR AF:  0.00000770  AC: 1AN: 129882Hom.:  0  Cov.: 19 AF XY:  0.00  AC XY: 0AN XY: 62088 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. 
GnomAD4 genome 
Data not reliable, filtered out with message: AS_VQSR
 AF: 
AC: 
1
AN: 
129882
Hom.: 
Cov.: 
19
 AF XY: 
AC XY: 
0
AN XY: 
62088
show subpopulations 
 ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. 
African (AFR) 
 AF: 
AC: 
0
AN: 
30850
American (AMR) 
 AF: 
AC: 
0
AN: 
12654
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3250
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
4894
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
3882
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
8522
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
300
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
62988
Other (OTH) 
 AF: 
AC: 
0
AN: 
1712
 ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals. 
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.275 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.